Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Impact on Clinical Decision Making of Next-Generation Sequencing in Pediatric Epilepsy in a Tertiary Epilepsy Referral Center.

Hoelz H, Herdl C, Gerstl L, Tacke M, Vill K, von Stuelpnagel C, Rost I, Hoertnagel K, Abicht A, Hollizeck S, Larsen LHG, Borggraefe I.

Clin EEG Neurosci. 2019 Sep 25:1550059419876518. doi: 10.1177/1550059419876518. [Epub ahead of print]

PMID:
31554424
2.

Arterial ischemic stroke in infants, children, and adolescents: results of a Germany-wide surveillance study 2015-2017.

Gerstl L, Weinberger R, Heinen F, Bonfert MV, Borggraefe I, Schroeder AS, Tacke M, Landgraf MN, Vill K, Kurnik K, Sorg AL, Olivieri M.

J Neurol. 2019 Aug 23. doi: 10.1007/s00415-019-09508-5. [Epub ahead of print]

PMID:
31444560
3.

Epilepsy surgery in the first months of life: a large type IIb focal cortical dysplasia causing neonatal drug-resistant epilepsy.

Borggraefe I, Tacke M, Gerstl L, Leiz S, Coras R, Blümcke I, Giese A, Ertl-Wagner B, Thiel CT, Noachtar S, Peraud A.

Epileptic Disord. 2019 Feb 1;21(1):122-127. doi: 10.1684/epd.2019.1037.

PMID:
30782583
4.

Antiepileptic therapy approaches in KCNQ2 related epilepsy: A systematic review.

Kuersten M, Tacke M, Gerstl L, Hoelz H, Stülpnagel CV, Borggraefe I.

Eur J Med Genet. 2019 Feb 14. pii: S1769-7212(18)30663-3. doi: 10.1016/j.ejmg.2019.02.001. [Epub ahead of print] Review.

PMID:
30771507
5.

SACS variants are a relevant cause of autosomal recessive hereditary motor and sensory neuropathy.

Vill K, Müller-Felber W, Gläser D, Kuhn M, Teusch V, Schreiber H, Weis J, Klepper J, Schirmacher A, Blaschek A, Wiessner M, Strom TM, Dräger B, Hofmeister-Kiltz K, Tacke M, Gerstl L, Young P, Horvath R, Senderek J.

Hum Genet. 2018 Dec;137(11-12):911-919. doi: 10.1007/s00439-018-1952-6. Epub 2018 Nov 21.

PMID:
30460542
6.

Symptom patterns in childhood arterial ischemic stroke: Analysis of a population-based study in Germany.

Gerstl L, Weinberger R, von Kries R, Heinen F, Sebastian Schroeder A, Veronika Bonfert M, Borggräfe I, Tacke M, Vill K, N Landgraf M, Kurnik K, Olivieri M.

Klin Padiatr. 2018 Oct;230(6):319-325. doi: 10.1055/a-0684-9794. Epub 2018 Oct 10.

PMID:
30304740
7.

Benign epilepsy with centrotemporal spikes: Correlating spike frequency and neuropsychology.

Tacke M, Rupp N, Gerstl L, Heinen F, Vill K, Bonfert M, Neubauer BA, Bast T, Borggraefe I; Further Members of the German HEAD Study Group.

Acta Neurol Scand. 2018 Dec;138(6):475-481. doi: 10.1111/ane.13015. Epub 2018 Sep 19.

PMID:
30259965
8.

Mesial Temporal Sclerosis in SCN1A-Related Epilepsy: Two Long-Term EEG Case Studies.

Tiefes AM, Hartlieb T, Tacke M, von Stülpnagel-Steinbeis C, Larsen LHG, Hao Q, Dahl HA, Neubauer BA, Gerstl L, Kudernatsch M, Kluger GJ, Borggraefe I.

Clin EEG Neurosci. 2019 Jul;50(4):267-272. doi: 10.1177/1550059418794347. Epub 2018 Aug 17.

PMID:
30117335
9.

Synthesis and Cytotoxicity Studies of Novel NHC*-Gold(I) Complexes Derived from Lepidiline A.

Curran D, Dada O, Müller-Bunz H, Rothemund M, Sánchez-Sanz G, Schobert R, Zhu X, Tacke M.

Molecules. 2018 Aug 14;23(8). pii: E2031. doi: 10.3390/molecules23082031.

10.

Childhood Stroke: Awareness, Interest, and Knowledge Among the Pediatric Community.

Bonfert MV, Badura K, Gerstl J, Borggraefe I, Heinen F, Schroeder S, Olivieri M, Weinberger R, Landgraf MN, Vill K, Tacke M, Berweck S, Reiter K, Hoffmann F, Nicolai T, Gerstl L.

Front Pediatr. 2018 Jun 25;6:182. doi: 10.3389/fped.2018.00182. eCollection 2018.

11.

Synthesis and Biological Evaluation of Homogeneous Thiol-Linked NHC*-Au-Albumin and -Trastuzumab Bioconjugates.

Matos MJ, Labão-Almeida C, Sayers C, Dada O, Tacke M, Bernardes GJL.

Chemistry. 2018 Aug 22;24(47):12250-12253. doi: 10.1002/chem.201800872. Epub 2018 May 22.

12.

Effects of Levetiracetam and Sulthiame on EEG in benign epilepsy with centrotemporal spikes: A randomized controlled trial.

Tacke M, Borggraefe I, Gerstl L, Heinen F, Vill K, Bonfert M, Bast T; HEAD Study group, Neubauer BA, Baumeister F, Baethmann M, Bentele K, Blank C, Blank HM, Bode H, Bosch F, Brandl U, Brockmann K, Dahlem P, Ernst JP, Feldmann E, Fiedler A, Gerigk M, Heß S, Hikel C, Hoffmann HG, Kieslich M, Klepper J, Kluger G, Koch H, Koch W, Korinthenberg R, Krois I, Kühne H, Kurlemann G, Mandl M, Mause U, Navratil P, Opp J, Penzien J, Prietsch V, Quattländer A, Rating D, Schara U, Shamdeen MG, Sprinz A, Wendker-Magrabi H, Stephani U, Muhle H, Straßburg HM, Töpke B, Trollmann R, Tuschen-Hofstätter E, Waltz S, Weber G, Wien FU, Wolff M, Polster T, Freitag H, Sönmez Ö, Reinhardt K, Traus M, Hoovey Z.

Seizure. 2018 Mar;56:115-120. doi: 10.1016/j.seizure.2018.01.015. Epub 2018 Feb 3.

13.

Risk factors in childhood arterial ischaemic stroke: Findings from a population-based study in Germany.

Gerstl L, Weinberger R, von Kries R, Heinen F, Schroeder AS, Bonfert MV, Borggraefe I, Tacke M, Vill K, Landgraf MN, Kurnik K, Olivieri M.

Eur J Paediatr Neurol. 2018 May;22(3):380-386. doi: 10.1016/j.ejpn.2018.01.001. Epub 2018 Jan 10.

PMID:
29370976
14.

Early-Onset Myopathies: Clinical Findings, Prevalence of Subgroups and Diagnostic Approach in a Single Neuromuscular Referral Center in Germany.

Vill K, Blaschek A, Gläser D, Kuhn M, Haack T, Alhaddad B, Wagner M, Kovacs-Nagy R, Tacke M, Gerstl L, Schroeder AS, Borggraefe I, Mueller C, Schlotter-Weigel B, Schoser B, Walter MC, Müller-Felber W.

J Neuromuscul Dis. 2017;4(4):315-325. doi: 10.3233/JND-170231.

PMID:
29172004
15.

[Epilepsy-new diagnostic tools, old drugs? : Therapeutic consequences of epilepsy genetics].

Tacke M, Neubauer BA, Gerstl L, Roser T, Rémi J, Borggraefe I.

Nervenarzt. 2017 Dec;88(12):1385-1394. doi: 10.1007/s00115-017-0427-7. Review. German.

PMID:
28932874
16.

Corrigendum to "EEG changes in rolandic epilepsy under treatment with Levetiracetam and Sulthiame" [Eur J Paediatr Neurol 21 (Suppl. 1) (June 2017) e97].

Tacke M, Borggraefe I, Gerstl L, Heinen F, Vill K, Bonfert M, Bast T.

Eur J Paediatr Neurol. 2017 Nov;21(6):e1. doi: 10.1016/j.ejpn.2017.07.021. Epub 2017 Aug 7. No abstract available.

PMID:
28797736
17.

Childhood-Onset Epileptic Encephalopathy Associated With Isolated Focal Cortical Dysplasia and a Novel TSC1 Germline Mutation.

Hoelz H, Coppenrath E, Hoertnagel K, Roser T, Tacke M, Gerstl L, Borggraefe I.

Clin EEG Neurosci. 2018 May;49(3):187-191. doi: 10.1177/1550059417697841. Epub 2017 Mar 7.

PMID:
28762286
18.

The non-isomorphous crystal structures of NHC-Au-Cl and NHC-Au-Br (NHC is 1,3-dibenzyl-4,5-diphenylimidazol-2-ylidene).

Tacke M, Dada O, O'Beirne C, Zhu X, Müller-Bunz H.

Acta Crystallogr C Struct Chem. 2016 Nov 1;72(Pt 11):857-860. Epub 2016 Oct 5.

PMID:
27811426
19.

Effect of anticonvulsive treatment on neuropsychological performance in children with BECTS.

Tacke M, Gerstl L, Heinen F, Heukaeufer I, Bonfert M, Bast T, Cornell S, Neubauer BA, Borggraefe I; German HEAD Study group.

Eur J Paediatr Neurol. 2016 Nov;20(6):874-879. doi: 10.1016/j.ejpn.2016.07.015. Epub 2016 Jul 25.

PMID:
27553576
20.

The "seagull cry": An initial sign in a child with intracranial carotid stenosis.

Gerstl L, Heinen F, Schroeder AS, Tacke M, Olivieri M, Dorn F, Voll C, Borggraefe I.

Neurology. 2016 Aug 23;87(8):850-1. doi: 10.1212/WNL.0000000000003012. No abstract available.

PMID:
27550894
21.

Successful mechanical thrombectomy in a three-year-old boy with cardioembolic occlusion of both the basilar artery and the left middle cerebral artery.

Gerstl L, Olivieri M, Heinen F, Borggraefe I, Schroeder AS, Tacke M, Vill K, Dalla-Pozza R, Reiter K, Lutz J, Brueckmann H, Janssen H.

Eur J Paediatr Neurol. 2016 Nov;20(6):962-965. doi: 10.1016/j.ejpn.2016.07.014. Epub 2016 Jul 25.

PMID:
27477566
22.

N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs.

Patil SA, Patil SA, Patil R, Keri RS, Budagumpi S, Balakrishna GR, Tacke M.

Future Med Chem. 2015;7(10):1305-33. doi: 10.4155/fmc.15.61. Review.

PMID:
26144266
23.

No clinically significant lymphocyte count change in pediatric patients treated with levetiracetam.

Tacke M, Borggraefe I.

Epilepsy Res. 2015 Aug;114:147-8. doi: 10.1016/j.eplepsyres.2015.04.001. Epub 2015 Apr 15. No abstract available.

PMID:
25921333
24.

The activity and localization patterns of cathepsins B and X in cells of the mouse gastrointestinal tract differ along its length.

Tamhane T, Arampatzidou M, Gerganova V, Tacke M, Illukkumbura R, Dauth S, Schaschke N, Peters C, Reinheckel T, Brix K.

Biol Chem. 2014 Oct;395(10):1201-19. doi: 10.1515/hsz-2014-0151.

PMID:
25205730
25.

Assessment of in vivo antimicrobial activity of the carbene silver(I) acetate derivative SBC3 using Galleria mellonella larvae.

Browne N, Hackenberg F, Streciwilk W, Tacke M, Kavanagh K.

Biometals. 2014 Aug;27(4):745-52. doi: 10.1007/s10534-014-9766-z. Epub 2014 Jul 19.

PMID:
25037059
26.

Benzyl-substituted metallocarbene antibiotics and anticancer drugs.

Hackenberg F, Tacke M.

Dalton Trans. 2014 Jun 14;43(22):8144-53. doi: 10.1039/c4dt00624k. Epub 2014 Apr 28. Review.

PMID:
24770329
27.

Development of bispecific molecules for the in situ detection of protein-protein interactions and protein phosphorylation.

van Dieck J, Schmid V, Heindl D, Dziadek S, Schraeml M, Gerg M, Massoner P, Engel AM, Tiefenthaler G, Vural S, Stritt S, Tetzlaff F, Soukupova M, Kopetzki E, Bossenmaier B, Thomas M, Klein C, Mertens A, Heller A, Tacke M.

Chem Biol. 2014 Mar 20;21(3):357-68. doi: 10.1016/j.chembiol.2013.12.018. Epub 2014 Feb 13.

28.

Resting energy expenditure and the effects of muscle wasting in patients with chronic heart failure: results from the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF).

Tacke M, Ebner N, Boschmann M, Jarius A, Valentova M, Fülster S, Sandek A, Schomburg L, Anker SD, Doehner W, von Haehling S.

J Am Med Dir Assoc. 2013 Nov;14(11):837-41. doi: 10.1016/j.jamda.2013.08.008. Epub 2013 Oct 2.

PMID:
24094897
29.

Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression.

Bengsch F, Buck A, Günther SC, Seiz JR, Tacke M, Pfeifer D, von Elverfeldt D, Sevenich L, Hillebrand LE, Kern U, Sameni M, Peters C, Sloane BF, Reinheckel T.

Oncogene. 2014 Sep 4;33(36):4474-84. doi: 10.1038/onc.2013.395. Epub 2013 Sep 30.

30.

Mutations in LRPAP1 are associated with severe myopia in humans.

Aldahmesh MA, Khan AO, Alkuraya H, Adly N, Anazi S, Al-Saleh AA, Mohamed JY, Hijazi H, Prabakaran S, Tacke M, Al-Khrashi A, Hashem M, Reinheckel T, Assiri A, Alkuraya FS.

Am J Hum Genet. 2013 Aug 8;93(2):313-20. doi: 10.1016/j.ajhg.2013.06.002. Epub 2013 Jul 3.

31.

A comparative chemical-biological evaluation of titanium(IV) complexes with a salan or cyclopentadienyl ligand.

Schur J, Manna CM, Deally A, Köster RW, Tacke M, Tshuva EY, Ott I.

Chem Commun (Camb). 2013 May 25;49(42):4785-7. doi: 10.1039/c3cc38604j.

PMID:
23598498
32.

Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF).

Fülster S, Tacke M, Sandek A, Ebner N, Tschöpe C, Doehner W, Anker SD, von Haehling S.

Eur Heart J. 2013 Feb;34(7):512-9. doi: 10.1093/eurheartj/ehs381. Epub 2012 Nov 23.

PMID:
23178647
33.
34.

Assessment of serum cotinine in patients with chronic heart failure: self-reported versus objective smoking behaviour.

Ebner N, Földes G, Szabo T, Tacke M, Fülster S, Sandek A, Doehner W, Anker SD, von Haehling S.

Clin Res Cardiol. 2013 Feb;102(2):95-101. doi: 10.1007/s00392-012-0499-0. Epub 2012 Aug 10.

PMID:
22878732
35.

Synthesis and biological evaluation of achiral indole-substituted titanocene dichloride derivatives.

Deally A, Hackenberg F, Lally G, Tacke M.

Int J Med Chem. 2012;2012:905981. doi: 10.1155/2012/905981. Epub 2012 Jun 12.

36.

Gold(I)-NHC complexes of antitumoral diarylimidazoles: structures, cellular uptake routes and anticancer activities.

Kaps L, Biersack B, Müller-Bunz H, Mahal K, Münzner J, Tacke M, Mueller T, Schobert R.

J Inorg Biochem. 2012 Jan;106(1):52-8. doi: 10.1016/j.jinorgbio.2011.08.026. Epub 2011 Sep 14.

PMID:
22112840
37.

The role of the intrinsic FAS pathway in Titanocene Y apoptosis: The mechanism of overcoming multiple drug resistance in malignant leukemia cells.

Kater L, Claffey J, Hogan M, Jesse P, Kater B, Strauss S, Tacke M, Prokop A.

Toxicol In Vitro. 2012 Feb;26(1):119-24. doi: 10.1016/j.tiv.2011.09.010. Epub 2011 Oct 1.

PMID:
21986259
38.

Cellular senescence induced by cathepsin X downregulation.

Kraus S, Bunsen T, Schuster S, Cichoń MA, Tacke M, Reinheckel T, Sommerhoff CP, Jochum M, Nägler DK.

Eur J Cell Biol. 2011 Aug;90(8):678-86. doi: 10.1016/j.ejcb.2011.03.008. Epub 2011 May 26.

PMID:
21616554
39.

Novel benzyl-substituted N-heterocyclic carbene-silver acetate complexes: synthesis, cytotoxicity and antibacterial studies.

Patil S, Deally A, Gleeson B, Müller-Bunz H, Paradisi F, Tacke M.

Metallomics. 2011 Jan;3(1):74-88. doi: 10.1039/c0mt00034e. Epub 2010 Dec 6.

PMID:
21135954
40.

A combination of serum markers for the early detection of colorectal cancer.

Wild N, Andres H, Rollinger W, Krause F, Dilba P, Tacke M, Karl J.

Clin Cancer Res. 2010 Dec 15;16(24):6111-21. doi: 10.1158/1078-0432.CCR-10-0119. Epub 2010 Aug 26.

41.

Effects of titanocene dichloride derivatives on prostate cancer cells, specifically DNA damage-induced apoptosis.

Cuffe S, Dowling CM, Claffey J, Pampillón C, Hogan M, Fitzpatrick JM, Carty MP, Tacke M, Watson RW.

Prostate. 2011 Feb 1;71(2):111-24. doi: 10.1002/pros.21227.

PMID:
20665530
42.

Electromagnetic real-time tumor position monitoring and dynamic multileaf collimator tracking using a Siemens 160 MLC: geometric and dosimetric accuracy of an integrated system.

Krauss A, Nill S, Tacke M, Oelfke U.

Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):579-87. doi: 10.1016/j.ijrobp.2010.03.043. Epub 2010 Jul 23.

PMID:
20656420
43.

Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor.

Masset A, Maillard C, Sounni NE, Jacobs N, Bruyére F, Delvenne P, Tacke M, Reinheckel T, Foidart JM, Coussens LM, Noël A.

Int J Cancer. 2011 Jan 15;128(2):283-93. doi: 10.1002/ijc.25326. Epub 2010 Mar 15.

44.

Real-time tumor tracking: automatic compensation of target motion using the Siemens 160 MLC.

Tacke MB, Nill S, Krauss A, Oelfke U.

Med Phys. 2010 Feb;37(2):753-61.

PMID:
20229885
45.

Anticancer activity and mode of action of titanocene C.

Olszewski U, Claffey J, Hogan M, Tacke M, Zeillinger R, Bednarski PJ, Hamilton G.

Invest New Drugs. 2011 Aug;29(4):607-14. doi: 10.1007/s10637-010-9395-5. Epub 2010 Feb 17.

PMID:
20162321
46.

Lysosomal membrane permeabilization and cathepsin release is a Bax/Bak-dependent, amplifying event of apoptosis in fibroblasts and monocytes.

Oberle C, Huai J, Reinheckel T, Tacke M, Rassner M, Ekert PG, Buellesbach J, Borner C.

Cell Death Differ. 2010 Jul;17(7):1167-78. doi: 10.1038/cdd.2009.214. Epub 2010 Jan 22.

47.

Titanocene difluorides with improved cytotoxic activity.

Eger S, Immel TA, Claffey J, Müller-Bunz H, Tacke M, Groth U, Huhn T.

Inorg Chem. 2010 Feb 15;49(4):1292-4. doi: 10.1021/ic9022163.

PMID:
20055428
48.

Binding and hydrolysis studies of antitumoural titanocene dichloride and Titanocene Y with phosphate diesters.

Erxleben A, Claffey J, Tacke M.

J Inorg Biochem. 2010 Apr;104(4):390-6. doi: 10.1016/j.jinorgbio.2009.11.010. Epub 2009 Dec 3.

PMID:
20036426
49.

Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis.

Dennemärker J, Lohmüller T, Mayerle J, Tacke M, Lerch MM, Coussens LM, Peters C, Reinheckel T.

Oncogene. 2010 Mar 18;29(11):1611-21. doi: 10.1038/onc.2009.466. Epub 2009 Dec 21.

50.

Pseudo-halide derivatives of titanocene: synthesis and cytotoxicity studies.

Claffey J, Deally A, Gleeson B, Hogan M, Méndez LM, Müller-Bunz H, Patil S, Wallis D, Tacke M.

Metallomics. 2009 Nov;1(6):511-7. doi: 10.1039/b911753a. Epub 2009 Sep 2.

PMID:
21305159

Supplemental Content

Support Center